Experiment 1312853
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Trichosanthes kirilowii (CUCURBITACEAE) |
| Citation | SONG,YW; LEE,EY: KOH,EM: CHA,HS: YOO,B: LEE,CK: BAEK,HJ: KIM,HA: SUH,YI: KANG,SW: LEE,YJ: JUNG,HG:. (2007). ASSESSMENT OF COMPARATIVE PAIN RELIEF AND TOLERABILITY OF SKI306X COMPARED WITH CELECOXIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: DOUBLE-BLIND, DOUBLE-DUMMY, PHASE III, NONINFERIORITY CLINICAL TRIAL. 29(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | SKI306X, WHICH CONSISTS OF BIOLOGICALLY ACTIVE INGREDIENTS FROM CLEMATIS MANDSCHURICA, TRICOSANTES KIRILOWII, AND PRUNELLA VULGARIS, WAS DEVELOPED AND TESTED IN PRECLINICAL TRIALS IN KOREA. THOSE STUDIES FOUND THAT SKI306X WAS ASSOCIATED WITH AN ANTI-INFLAMMATORY AND ANALGESIC EFFECT, AND THAT IT CAN DELAY THE DESTRUCTION OF CARTILAGE IN RHEUMATOID ARTHRITIS (RA). |
| Dose amount | 200 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | TYPE EXT NOT STATED |